Scientists Question Data Behind an Experimental Alzheimer’s Drug

In its papers, Cassava has said that the theory is supported by strong evidence. “But in fact, all the evidence seems to be from this lab,” said Dr. Lawrence Honig, an Alzheimer’s disease expert at Columbia. ... Dr. Honig said the company’s reliance on an outdated lab technique called Western blotting, used to detect proteins, was unusual because it does not have “the sensitivity or reproducibility or accuracy” of newer methods. [read more]

Source: The New York Times